Ranbaxy Laboratories has placed a net loss of Rs464.58 cr

Ranbaxy Laboratories has placed a net loss of Rs464.58 cr for the qtr closed Sept 30, 2011 when compared to net gain of Rs307.94 cr for the qtr closed Sept 30, 2010.

The total revenue of the group surged by 8.71percent to Rs2197.56 cr for the qtr closed Sept 30, 2011 from Rs2021.58 cr for the qtr closed Sept 30, 2010.

Be Sociable, Share!
Tags:

Stock Market Basics For Beginners

What is Support And Resistance?

What is Support And Resistance? One of several interesting phenomena of share markets that are usually catchy is a activity of share prices at the blink of eyes. At one ...…

The emerging countries(markets)

The emerging countries(markets) The emerging markets (nations) have seen fundamental and structural modifications in their economies and financial markets in the research time period, approximately 1993-2005. Table one ...…

Primary Markets?

Primary Markets? The market in which investors have the initial opportunity to buy a newly issued security ( IPO ). Companies and other groups obtain financing through ...…

Invest For Long Time Period And Never Short Time Period

Invest For Long Time Period And Never Short Time Period Invest for Long Time period and never Short Time period : When you determine that your cash can work for you above a long ...…

Why India & China Can Be Favorite Destinations For Investments Globally With Reasons

Why India & China Can Be Favorite Destinations For Investments Globally With Reasons India & China, the Asian giants are the only countries in the world to grow more than 8% per annum. China is growing at a ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics